Mila Fabris | Associate Director, Patient Safety
Gilead Sciences

Mila Fabris, MD, serves as Associate Director, Patient Safety, Medical Device Safety at Gilead Sciences, where she supports safety oversight and pharmacovigilance activities across the product lifecycle. A physician by background, Mila spent five years in clinical practice before moving into drug safety. Her bedside experience shapes her focus on patient-centered safety, clear risk communication, and closing the system gaps that allow adverse events to occur.

Appearances:

Day 1: 14th October @ 09:50

Panel - The Autonomous Safety Future: Human Judgement + AI Scale

Escalating adverse event volumes, increasingly complex therapies, and growing regulatory expectations are testing the limits of traditional, human-intensive safety models. The future of patient safety will not be defined by artificial intelligence alone. It will be shaped by a new partnership: human judgment and AI at scale. This keynote panel discussion will explore how autonomous agentic AI systems are transforming safety operations from reactive monitoring to predictive assurance and accelerate decision-making. The panel will also throw light on where human judgement will remain critical, what new skills will define future roles and how will the safety function ultimately.

Moderator: Monica Mayk, Head of Marketing, Human Impact Industries, TCS

Prithwiraj Ghosh, Vice President & Business Unit Head, Life Sciences and Healthcare, TCS